• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三种中低收入国家的慢性阻塞性肺疾病自我管理:一项试点随机试验。

Chronic Obstructive Pulmonary Disease Self-Management in Three Low- and Middle-Income Countries: A Pilot Randomized Trial.

机构信息

Division of Pulmonary and Critical Care.

Center for Global Non-Communicable Disease Research and Training, School of Medicine, and.

出版信息

Am J Respir Crit Care Med. 2023 Nov 15;208(10):1052-1062. doi: 10.1164/rccm.202303-0505OC.

DOI:10.1164/rccm.202303-0505OC
PMID:37698443
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10867931/
Abstract

Chronic obstructive pulmonary disease (COPD) disproportionately affects low- and middle-income countries. Health systems are ill prepared to manage the increase in COPD cases. We performed a pilot effectiveness-implementation randomized field trial of a community health worker (CHW)-supported, 1-year self-management intervention in individuals with COPD grades B-D. The study took place in low-resource settings of Nepal, Peru, and Uganda. The primary outcome was the St. George's Respiratory Questionnaire (SGRQ) score at 1 year. We evaluated differences in moderate to severe exacerbations, all-cause hospitalizations, and the EuroQol score (EQ-5D-3 L) at 12 months. We randomly assigned 239 participants (119 control arm, 120 intervention arm) with grades B-D COPD to a multicomponent, CHW-supported intervention or standard of care and COPD education. Twenty-five participants (21%) died or were lost to follow-up in the control arm compared with 11 (9%) in the intervention arm. At 12 months, there was no difference in mean total SGRQ score between the intervention and control arms (34.7 vs. 34.0 points; adjusted mean difference, 1.0; 95% confidence interval, -4.2, 6.1;  = 0.71). The intervention arm had a higher proportion of hospitalizations than the control arm (10% vs. 5.2%; adjusted odds ratio, 2.2; 95% confidence interval, 0.8, 7.5;  = 0.15) at 12 months. A CHW-based intervention to support self-management of acute exacerbations of COPD in three resource-poor settings did not result in differences in SGRQ scores at 1 year. Fidelity was high, and intervention engagement was moderate. Although these results cannot differentiate between a failed intervention or implementation, they nonetheless suggest that we need to revisit our strategy. Clinical trial registered with www.clinicaltrials.gov (NCT03359915).

摘要

慢性阻塞性肺疾病(COPD)在中低收入国家的发病率较高。卫生系统尚未准备好应对 COPD 病例的增加。我们在尼泊尔、秘鲁和乌干达的资源匮乏地区开展了一项关于社区卫生工作者(CHW)支持的为期 1 年 COPD 患者自我管理干预的试点有效性-实施随机现场试验。主要结局指标为 1 年时的圣乔治呼吸问卷(SGRQ)评分。我们评估了 12 个月时中度至重度恶化、全因住院和 EQ-5D-3L 评分的差异。我们将 239 名 B-D 级 COPD 患者随机分为多组分、CHW 支持的干预组或对照组(标准护理和 COPD 教育)。对照组有 25 名(21%)参与者死亡或失访,而干预组有 11 名(9%)。12 个月时,干预组和对照组之间 SGRQ 总分平均差异无统计学意义(34.7 对 34.0 分;调整平均差异,1.0;95%置信区间,-4.2,6.1; = 0.71)。与对照组相比,干预组的住院率更高(10%对 5.2%;调整比值比,2.2;95%置信区间,0.8,7.5; = 0.15)。在三个资源匮乏的地区,基于 CHW 的干预措施来支持 COPD 急性加重的自我管理,并未导致 1 年后 SGRQ 评分的差异。一致性很高,干预参与率为中等。尽管这些结果无法区分干预失败或实施失败,但它们表明我们需要重新审视我们的策略。该临床试验已在 www.clinicaltrials.gov(NCT03359915)注册。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a44/10867931/e6719385d18b/rccm.202303-0505OCf3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a44/10867931/e91bc5f1392d/rccm.202303-0505OCf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a44/10867931/3d764383fcb3/rccm.202303-0505OCf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a44/10867931/e6719385d18b/rccm.202303-0505OCf3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a44/10867931/e91bc5f1392d/rccm.202303-0505OCf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a44/10867931/3d764383fcb3/rccm.202303-0505OCf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a44/10867931/e6719385d18b/rccm.202303-0505OCf3.jpg

相似文献

1
Chronic Obstructive Pulmonary Disease Self-Management in Three Low- and Middle-Income Countries: A Pilot Randomized Trial.三种中低收入国家的慢性阻塞性肺疾病自我管理:一项试点随机试验。
Am J Respir Crit Care Med. 2023 Nov 15;208(10):1052-1062. doi: 10.1164/rccm.202303-0505OC.
2
Effectiveness-implementation of COPD case finding and self-management action plans in low- and middle-income countries: global excellence in COPD outcomes (GECo) study protocol.慢性阻塞性肺疾病(COPD)病例发现及自我管理行动计划在低收入和中等收入国家的有效性实施:慢性阻塞性肺疾病全球卓越成果(GECo)研究方案
Trials. 2018 Oct 19;19(1):571. doi: 10.1186/s13063-018-2909-8.
3
4
Effect of a Program Combining Transitional Care and Long-term Self-management Support on Outcomes of Hospitalized Patients With Chronic Obstructive Pulmonary Disease: A Randomized Clinical Trial.联合过渡期护理和长期自我管理支持的方案对慢性阻塞性肺疾病住院患者结局的影响:一项随机临床试验。
JAMA. 2018 Dec 11;320(22):2335-2343. doi: 10.1001/jama.2018.17933.
5
Effect of a Hospital-Initiated Program Combining Transitional Care and Long-term Self-management Support on Outcomes of Patients Hospitalized With Chronic Obstructive Pulmonary Disease: A Randomized Clinical Trial.医院发起的联合过渡期护理和长期自我管理支持计划对慢性阻塞性肺疾病住院患者结局的影响:一项随机临床试验。
JAMA. 2019 Oct 8;322(14):1371-1380. doi: 10.1001/jama.2019.11982.
6
Comparing Self-Management Programs with and without Peer Support among Patients with Chronic Obstructive Pulmonary Disease: A Clinical Trial.比较慢性阻塞性肺疾病患者中有无同伴支持的自我管理计划:一项临床试验。
Ann Am Thorac Soc. 2022 Oct;19(10):1687-1696. doi: 10.1513/AnnalsATS.202108-932OC.
7
Effectiveness of low-dose theophylline for the management of biomass-associated COPD (LODOT-BCOPD): study protocol for a randomized controlled trial.低剂量茶碱治疗生物量相关 COPD(LODOT-BCOPD)的疗效:一项随机对照试验的研究方案。
Trials. 2021 Mar 16;22(1):213. doi: 10.1186/s13063-021-05163-2.
8
Self-management support for moderate-to-severe chronic obstructive pulmonary disease: a pilot randomised controlled trial.中重度慢性阻塞性肺疾病的自我管理支持:一项初步随机对照试验。
Br J Gen Pract. 2012 Oct;62(603):e687-95. doi: 10.3399/bjgp12X656829.
9
Technology-Enabled Self-Management of Chronic Obstructive Pulmonary Disease With or Without Asynchronous Remote Monitoring: Randomized Controlled Trial.基于技术的慢性阻塞性肺疾病患者自我管理,无论是否有异步远程监测:随机对照试验。
J Med Internet Res. 2020 Jul 30;22(7):e18598. doi: 10.2196/18598.
10
A randomised controlled equivalence trial to determine the effectiveness and cost-utility of manual chest physiotherapy techniques in the management of exacerbations of chronic obstructive pulmonary disease (MATREX).一项随机对照等效试验,旨在确定手动胸部物理治疗技术在慢性阻塞性肺疾病(MATREX)急性加重期管理中的有效性和成本效用。
Health Technol Assess. 2010 May;14(23):1-147, iii-iv. doi: 10.3310/hta14230.

引用本文的文献

1
Evaluating the impact of self-management interventions on COPD outcomes in low- and middle-income countries in Asia: a systematic review.评估自我管理干预措施对亚洲低收入和中等收入国家慢性阻塞性肺疾病结局的影响:一项系统评价。
Health Qual Life Outcomes. 2025 Aug 30;23(1):81. doi: 10.1186/s12955-025-02382-y.
2
The Exacerbation, Not the Patient, Determines Chronic Obstructive Pulmonary Disease Exacerbation Care Seeking.慢性阻塞性肺疾病急性加重期的就医行为取决于急性加重情况,而非患者自身。
Ann Am Thorac Soc. 2024 Apr;21(4):541-542. doi: 10.1513/AnnalsATS.202401-010ED.
3
Early Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease: The Costs and Benefits of Case Finding.

本文引用的文献

1
Unmet Diagnostic and Therapeutic Opportunities for Chronic Obstructive Pulmonary Disease in Low- and Middle-Income Countries.中低收入国家慢性阻塞性肺疾病诊治未满足需求的机会。
Am J Respir Crit Care Med. 2023 Aug 15;208(4):442-450. doi: 10.1164/rccm.202302-0289OC.
2
Availability, affordability and access to essential medications for asthma and chronic obstructive pulmonary disease in three low- and middle-income country settings.三个低收入和中等收入国家环境中哮喘和慢性阻塞性肺疾病基本药物的可及性、可负担性及获取情况。
PLOS Glob Public Health. 2022 Dec 16;2(12):e0001309. doi: 10.1371/journal.pgph.0001309. eCollection 2022.
3
慢性阻塞性肺疾病的早期诊断与治疗:病例发现的成本与效益
Am J Respir Crit Care Med. 2024 Apr 15;209(8):928-937. doi: 10.1164/rccm.202311-2120PP.
4
Role of Community Health Workers in Chronic Obstructive Pulmonary Disease Care in Low- and Middle-Income Countries.社区卫生工作者在低收入和中等收入国家慢性阻塞性肺疾病护理中的作用。
Am J Respir Crit Care Med. 2023 Nov 15;208(10):1012-1013. doi: 10.1164/rccm.202309-1640ED.
Discriminative Accuracy of Chronic Obstructive Pulmonary Disease Screening Instruments in 3 Low- and Middle-Income Country Settings.
在 3 个中低收入国家环境下,慢性阻塞性肺疾病筛查工具的鉴别准确性。
JAMA. 2022 Jan 11;327(2):151-160. doi: 10.1001/jama.2021.23065.
4
Self-management interventions for people with chronic obstructive pulmonary disease.针对慢性阻塞性肺疾病患者的自我管理干预措施。
Cochrane Database Syst Rev. 2022 Jan 10;1(1):CD002990. doi: 10.1002/14651858.CD002990.pub4.
5
Challenges in the Implementation of Chronic Obstructive Pulmonary Disease Guidelines in Low- and Middle-Income Countries: An Official American Thoracic Society Workshop Report.中低收入国家实施慢性阻塞性肺疾病指南的挑战:美国胸科学会官方研讨会报告。
Ann Am Thorac Soc. 2021 Aug;18(8):1269-1277. doi: 10.1513/AnnalsATS.202103-284ST.
6
Task-sharing interventions for improving control of diabetes in low-income and middle-income countries: a systematic review and meta-analysis.任务分担干预措施在改善中低收入国家糖尿病控制中的应用:系统评价和荟萃分析。
Lancet Glob Health. 2021 Feb;9(2):e170-e180. doi: 10.1016/S2214-109X(20)30449-6. Epub 2020 Nov 23.
7
Illness representations of chronic obstructive pulmonary disease (COPD) to inform health education strategies and research design-learning from rural Uganda.慢性阻塞性肺疾病(COPD)的疾病表现,以告知健康教育策略和研究设计——从乌干达农村学习。
Health Educ Res. 2020 Aug 1;35(4):258-269. doi: 10.1093/her/cyaa016.
8
Effect of a Hospital-Initiated Program Combining Transitional Care and Long-term Self-management Support on Outcomes of Patients Hospitalized With Chronic Obstructive Pulmonary Disease: A Randomized Clinical Trial.医院发起的联合过渡期护理和长期自我管理支持计划对慢性阻塞性肺疾病住院患者结局的影响:一项随机临床试验。
JAMA. 2019 Oct 8;322(14):1371-1380. doi: 10.1001/jama.2019.11982.
9
Application of the community health worker model in adult asthma and COPD in the U.S.: a systematic review.社区卫生工作者模式在美国成人哮喘和 COPD 中的应用:系统评价。
BMC Pulm Med. 2019 Jun 26;19(1):116. doi: 10.1186/s12890-019-0878-7.
10
Urban-Rural Disparities in Chronic Obstructive Pulmonary Disease Management and Access in Uganda.乌干达慢性阻塞性肺疾病管理与就医机会的城乡差异
Chronic Obstr Pulm Dis. 2019 Jan 4;6(1):17-28. doi: 10.15326/jcopdf.6.1.2018.0143.